LUNGevityHunter Posted November 16, 2021 Share Posted November 16, 2021 UPDATE- Nuvalent’s ROS1 trial; A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1), is now posted on Clinicaltrials.gov. SCRI (Dr. Johnson) and UCI (Dr. Ou) are both open to enrolling patients and the team is working hard to activate additional US sites this year. https://clinicaltrials.gov/ct2/show/NCT05118789?term=nuvalent&draw=2&rank=1 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.